CGM Metrics Linked to Cardiovascular Risk Beyond Fasting Glucose, HbA1c

This cross-sectional analysis from the Framingham Heart Study examined continuous glucose monitoring (CGM) data from 1,356 participants without diabetes or cardiovascular disease who wore a blinded Dexcom G6 Pro CGM for up to 10 days. The study reported that CGM measures, such as time spent above 140 mg/dL, were associated with higher 10-year cardiovascular disease risk estimates and higher odds of hypertension and dyslipidemia, even after adjusting for fasting plasma glucose. The authors noted that CGM-defined glycemic profiles often diverged from traditional prediabetes classifications based on fasting glucose and HbA1c, and that profiles reflecting higher dysglycemia were linked to elevated cardiovascular risk estimates and worse cardiometabolic risk factors.

Most relevant for: Adults without diagnosed diabetes or cardiovascular disease being evaluated for cardiometabolic risk, including those with normal or borderline fasting glucose and HbA1c results.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.